insitro in the News

For media inquiries, contact queries@insitro.com

On GPS: Koller talks AI & healthcare

Will A.I. find the cure for what ails you? Daphne Koller tells Fareed about how artificial intelligence can help save lives.

Daphne Koller, Founder & CEO of Insitro - In Conversation with Carlos Bustamante

Dr. Daphne Koller and Dr. Carlos Bustamante discuss machine learning, drug discovery, Eroom’s Law, and how data science is revolutionizing the life sciences.

Samsung CEO Summit: Human Biology through the Lens of Data

Declaring herself ‘bilingual’ in both machine learning and biology, Daphne Koller outlined the trajectory toward the integration of data and biology that will revolutionize medicine.

Out to ‘rethink the drug design process,’ AI star Daphne Koller is creating a new machine learning venture at insitro with some heavyweight backers

Daphne Koller has been busy.

Just two months since the high profile AI expert exited Google’s anti-aging biotech Calico Labs, where she was chief computing officer, Koller has gathered a group of marquee investors to back a tech upstart — insitro — with plans to develop a machine learning platform equipped with custom-built datasets to create a new and far more efficient approach to drug discovery and development…

Daphne Koller, A-list backers unite to create machine learning drug R&D startup

Daphne Koller has unveiled her next goal: improving drug R&D. The ex-Calico AI expert plans to enlist data and machines to address shortcomings in drug discovery and development—and she has persuaded a stellar investment syndicate to bankroll the work…

AI researcher Daphne Koller heading new machine learning drug discovery venture

In a recent medium.com blog post, Daphne Koller — an artificial intelligence researcher at the Department of Computer Science at Stanford University and, until just a few months ago, chief computing officer at Alphabet’s Calico Labs — announced her up-and-coming foray into machine learning-powered drug discovery…

Backed by big-name VCs, this startup is turning machine learning on drug discovery

Daphne Koller, the former ed-tech entrepreneur who jumped to anti-aging drug research company Calico, is launching a company turning machine learning on drug discovery and development with the backing of prominent biotech venture capital firms at the intersection of tech and biotech…